Determinants of Worsening Long Term Functional Outcomes in Patients Undergoing Myectomy

Overview

About this study

The purpose of this study is to

Establish the long term functional capacity of patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction
Establish patients who do not improve symptomatically on long term follow up
In patients, who do not have long term symptomatic improvement, ascertain predictors of poor outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Male and Female
Adults (18 years and older)
All consecutive patients with hypertrophic cardiomyopathy who underwent myectomy and have worsening functional status at long term follow up, as ascertained by IRB 12-001804

Exclusion Criteria:

Children (Less than 18 years old)
Patients whose functional status improved or stayed the same on long term follow up, as described by IRB 12-001804

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Hartzell Schaff, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Hartzell Schaff, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials